Publications

All      Ay      Benedict       Cheroutre       Croft       Crotty      Einav       Grifoni       Hogan       Kronenberg      Lisdestam Arlehamn      Myers      Peters      Rao      Reina      Saphire      Schmiedel      Schoenberger      Sette      Sharma      Shresta      Vijayanand      Weiskopf
Altman             Eschweiler      Hedrick       Kawakami      Ley      Pandurangan      Seumois      Von Herrath      
Jun 1, 2010
  • J Autoimmun

Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment

Van Belle TL, Juntti T, Liao J, von Herrath MG
Jun 1, 2010
  • Viral Immunol

Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology

Vaughan K, Greenbaum J, Blythe M, Peters B, Sette A
May 25, 2010
  • Proc Natl Acad Sci USA

Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells

Eidenschenk C, Crozat K, Krebs P, Arens R, Popkin D, Arnold CN, Blasius AL, Benedict CA, Moresco EM, Xia Y, Beutler B
May 21, 2010
  • Vaccine

Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans

Tan TG, Mui E, Cong H, Witola W, Montpetit A, Muench SP, Sidney J, Alexander J, Sette A, Grigg M, Maewal A, McLeod R
May 20, 2010
  • Blood

Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation

Schulz C, Leuschen NV, Frohlich T, Lorenz M, Pfeiler S, Gleissner CA, Kremmer E, Kessler M, Khandoga AG, Engelmann B, Ley K, Massberg S, Arnold GJ
May 10, 2010
  • J Exp Med

Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection

Engel I, Hammond K, Sullivan BA, He X, Taniuchi I, Kappes D, Kronenberg M
May 1, 2010
  • J Intern Med

Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything

Loewendorf A, Benedict CA
May 1, 2010
  • Hum Immunol

Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus

Alexander J, Bilsel P, del Guercio MF, Marinkovic-Petrovic A, Southwood S, Stewart S, Ishioka G, Kotturi MF, Botten J, Sidney J, Newman M, Sette A
May 1, 2010
  • J Allergy Clin Immunol

Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model

Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG
May 1, 2010
  • Immunol Rev

Plasticity in programming of effector and memory CD8 T-cell formation

Arens R, Schoenberger SP
May 1, 2010
  • J Rheumatol

Optimizing the use of tumor necrosis factor inhibitors in the management of immune-mediated inflammatory diseases

Bressler B, Heraoui B, Keystone E, Sette A
May 1, 2010
  • Bioorg Med Chem

Synthesis and evaluation of new N6-substituted adenosine-5′-N-methylcarboxamides as A3 adenosine receptor agonists

Devine SM, Gregg A, Figler H, McIntosh K, Urmaliya V, Linden J, Pouton CW, White PJ, Bottle SE, Scammells PJ
Facebook Youtube Linkedin Instagram

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2025 La Jolla Institute for Immunology. All rights reserved. LJI is a 501(c)(3) tax-exempt organization. Federal Tax ID Number 33-0328688